Home Site map RU | ENG | PT
Limassol
Moscow
Voskresensk
Kirovo-
Chepetsk
Berezniki
About URALCHEM Assets Products Corporate responsibility Investor relations Media center Contacts
Press-releases
30.04.2010

PRESS-RELEASE

Moscow, Russia – April 30, 2010 – URALCHEM Holding P.L.C. (“UralChem Holding” or “the Company”), a company incorporated in Cyprus and the holding company for URALCHEM Group, one of the largest producers of nitrogen fertilizers in Russia, today announces the decision to postpone its initial global offering (the “Offering”). The Company’s management and its shareholder believe that in the current market conditions the Offering cannot be priced
at a level which reflects a fair value of the Company.

Dmitry Mazepin, Chairman of the Board of Directors of URALCHEM Holding, commented: “Our Offering generated considerable demand by international institutional investors. However, we decided to postpone the IPO as we were not satisfied with the valuation that could be achieved in the current market conditions. Our Company has established market leading position in mineral fertilizers with a diversified portfolio of products and we are committed to increasing the value of URALCHEM Holding. We may consider a public offering at another time in the future.”

 

NOT FOR PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA

Notes to editors:
URALCHEM Group is a leading Russian mineral fertilizer producer with a diversified product portfolio consisting of ammonia and basic nitrogen and phosphate fertilizers such as urea, AN, MAP and DAP, as well as value-added market-tailored nitrogen-based fertilizers such as SAN, CAN, CNS and an extensive range of NPKs.

In 2009, URALCHEM Group was Russia’s largest producer of ammonium nitrate, as well as Russia’s second largest producer of nitrogen-based fertilizers, according to Azotecon. URALCHEM Group's products are distributed in approximately 60 countries including premium markets of the European Union and the high-growth markets of Latin America and Russia. In 2009, sales to Europe, Latin America and Russia accounted for 25.9%, 24.6% and 27.1%, respectively, of UralChem Group's total sales revenue.



***


For further information, please contact:

URALCHEM Investor Relations
Thomas Kiehn
Tel: +7 495 721 8989
thomas.kiehn@uralchem.com

Shared Value Limited
Larisa Kogut-Millings
Tel: +44 (0) 20 7321 5010
uralchem@sharedvalue.net


URALCHEM Holding P.L.C. is the holding company for URALCHEM Group which primarily consists of three mineral fertilizer production facilities in Russia. The Group is one of the largest producers of nitrogen and phosphate fertilizers in Russia and the CIS with production capacities of over 2.5 million tonnes of ammonium nitrate, 2.2 million tonnes of ammonia, 0.8 million tonnes of MAP and DAP, 0.8 million tonnes of compound fertilizers and 0.5 million tonnes of urea. URALCHEM Group’s three production facilities are located in the European part of Russia and include Kirovo-Chepetsk Chemical Works ("KCCW"), based in Kirovo-Chepetsk in the Kirov region; Azot ("Azot"), located in Berezniki in the Perm region; and Voskresensk Mineral Fertilizers ("VMF"), situated in Voskresensk in the Moscow region.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of the Company. You can identify forward-looking statements by terms such as "expect," "believe," "anticipate," "estimate," "intend," "will," "could," "may" or "might", the negative of such terms or other similar expressions. These statements are only predictions and actual events or results may differ materially. We do not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Many factors could cause the actual results to differ materially from those contained in our projections or forward-looking statements, including, among others, general economic conditions, our competitive environment, as well as many other risks specifically related to the Company and its operations.

The information contained herein does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

These materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for securities in the United States. The securities to which these materials relate have not been registered under the US Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act. The Company does not intend to register any part of the offering in the United States or to conduct a public offering of the securities in the United States.

Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") is only addressed to and is only directed at qualified investors in that Member State within the meaning of the Prospectus Directive.  These materials are only being distributed to and are only directed at (i) persons who are outside the United Kingdom, subject to applicable laws or (ii) persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2) of the Order (all such persons together being referred to as "relevant persons"). Any investment or investment activity to which these materials relate will only be available to and will only be engaged with relevant persons. Any person who is not a relevant person should not act or rely on this document or any of its contents.

These materials and information contained herein are not a public offer or advertisement of securities in Russia, and are not an offer, or an invitation to make offers, to purchase, sell, exchange or transfer any shares whether in the form of shares or GDRs in Russia. This information is not intended to be and must not be publicly distributed in the Russian Federation and is not intended to and must not be sent to persons who are not qualified investors under Russian law. No shares or GDRs have been or will be registered in Russia or are intended for placement or public circulation in Russia.

These materials and information contained herein do not constitute an offer of securities and nothing herein shall be read or construed as constituting investment advice or recommendations.

Each of Morgan Stanley & Co. International plc, Renaissance Securities (Cyprus) Limited, UBS Limited, UniCredit CAIB Securities UK Ltd. and Sberbank is acting for the Company and no one else in connection with the Offering and will not be responsible to anyone other than the Company for providing the protections afforded to its respective clients or for providing advice in relation to the contents of this announcement or any matters referred to herein.

 
© URALCHEM OJSC 2007-2012 Designed byFractalla Design  |  Developed by CMS DJEM ®

10, Presnenskaya Naberezhnaya, Moscow, Russia, 123317
tel +7 (495) 721 89 89, fax + 7 (495) 721 85 85
E-mail: